PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 153 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,834,000 | -6.8% | 67,002 | +3.3% | 0.25% | -15.2% |
Q2 2019 | $1,968,000 | +2.4% | 64,879 | +3.1% | 0.30% | -1.3% |
Q1 2019 | $1,921,000 | -1.4% | 62,958 | +0.0% | 0.30% | -4.2% |
Q4 2018 | $1,948,000 | +120.4% | 62,936 | +37.3% | 0.31% | +94.4% |
Q3 2018 | $884,000 | -38.5% | 45,847 | +20.5% | 0.16% | -45.4% |
Q2 2018 | $1,437,000 | +411.4% | 38,033 | +342.0% | 0.30% | +375.8% |
Q1 2018 | $281,000 | +5.6% | 8,605 | -62.8% | 0.06% | -12.7% |
Q4 2017 | $266,000 | -23.6% | 23,109 | +2.5% | 0.07% | -26.8% |
Q3 2017 | $348,000 | +65.7% | 22,542 | +501.8% | 0.10% | +61.7% |
Q2 2017 | $210,000 | -95.8% | 3,746 | +2781.5% | 0.06% | +252.9% |
Q1 2017 | $4,953,000 | -93.6% | 130 | -96.2% | 0.02% | -32.0% |
Q3 2016 | $77,312,000 | +37.5% | 3,430 | -27.9% | 0.02% | +257.1% |
Q2 2016 | $56,224,000 | – | 4,760 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |